BACKGROUND: Significant variability in weight loss and glycemic control has been observed in obese patients receiving bariatric surgery. Genetic factors may play a role in the different outcomes. METHODS: Five hundred and twenty severely obese patients with body mass index (BMI) ≥35 were recruited. Among them, 149 and 371 subjects received laparoscopic adjustable gastric banding (LAGB) and laparoscopic mini-gastric bypass (LMGB), respectively. All individuals were genotyped for five obesity-related single nucleotide polymorphisms on ESR1, FTO, PPARγ, and UCP2 genes to explore how these genes affect weight loss and glycemic control after bariatric surgery at the 6th month. RESULTS: Obese patients with risk genotypes on rs660339-UCP2 had greater decrease in BMI after LAGB compared to patients with non-risk genotypes (-7.5 vs. -6 U, p = 0.02). In contrast, after LMGB, obese patients with risk genotypes on either rs712221-ESR1 or rs9939609-FTO had significant decreases in BMI (risk vs. non-risk genotype, -12.5 vs. -10.0 U on rs712221, p = 0.02 and -12.1 vs. -10.6 U on rs9939609, p = 0.04) and a significant amelioration in HbA1c levels (p = 0.038 for rs712221 and p < 0.0001 for rs9939609). The synergic effect of ESR1 and FTO genes on HbA1c amelioration was greater (-1.54%, p for trend <0.001) than any of these genes alone in obese patients receiving LMGB. CONCLUSIONS: The genetic variants in the ESR, FTO, and UCP2 genes may be considered as a screening tool prior to bariatric surgery to help clinicians predict weight loss or glycemic control outcomes for severely obese patients.
BACKGROUND: Significant variability in weight loss and glycemic control has been observed in obesepatients receiving bariatric surgery. Genetic factors may play a role in the different outcomes. METHODS: Five hundred and twenty severely obesepatients with body mass index (BMI) ≥35 were recruited. Among them, 149 and 371 subjects received laparoscopic adjustable gastric banding (LAGB) and laparoscopic mini-gastric bypass (LMGB), respectively. All individuals were genotyped for five obesity-related single nucleotide polymorphisms on ESR1, FTO, PPARγ, and UCP2 genes to explore how these genes affect weight loss and glycemic control after bariatric surgery at the 6th month. RESULTS:Obesepatients with risk genotypes on rs660339-UCP2 had greater decrease in BMI after LAGB compared to patients with non-risk genotypes (-7.5 vs. -6 U, p = 0.02). In contrast, after LMGB, obesepatients with risk genotypes on either rs712221-ESR1 or rs9939609-FTO had significant decreases in BMI (risk vs. non-risk genotype, -12.5 vs. -10.0 U on rs712221, p = 0.02 and -12.1 vs. -10.6 U on rs9939609, p = 0.04) and a significant amelioration in HbA1c levels (p = 0.038 for rs712221 and p < 0.0001 for rs9939609). The synergic effect of ESR1 and FTO genes on HbA1c amelioration was greater (-1.54%, p for trend <0.001) than any of these genes alone in obesepatients receiving LMGB. CONCLUSIONS: The genetic variants in the ESR, FTO, and UCP2 genes may be considered as a screening tool prior to bariatric surgery to help clinicians predict weight loss or glycemic control outcomes for severely obesepatients.
Authors: E D Rosen; P Sarraf; A E Troy; G Bradwin; K Moore; D S Milstone; B M Spiegelman; R M Mortensen Journal: Mol Cell Date: 1999-10 Impact factor: 17.970
Authors: Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle Journal: Ann Intern Med Date: 2005-04-05 Impact factor: 25.391
Authors: Frederico G S Toledo; Elizabeta V Menshikova; Vladimir B Ritov; Koichiro Azuma; Zofia Radikova; James DeLany; David E Kelley Journal: Diabetes Date: 2007-05-29 Impact factor: 9.461
Authors: Timo D Müller; Anke Hinney; André Scherag; Thuy T Nguyen; Felix Schreiner; Helmut Schäfer; Johannes Hebebrand; Christian L Roth; Thomas Reinehr Journal: BMC Med Genet Date: 2008-09-17 Impact factor: 2.103
Authors: Daniel Antonio de Luis; Rocío Aller; Rosa Conde; Olatz Izaola; David Pacheco; Manuel Gonzalez Sagrado; David Primo Journal: J Gastrointest Surg Date: 2012-02-04 Impact factor: 3.452
Authors: Zhamak Khorgami; Kristopher L Arheart; Chi Zhang; Sarah E Messiah; Nestor de la Cruz-Muñoz Journal: Obes Surg Date: 2015-05 Impact factor: 4.129
Authors: Natália Luiza Kops; Manoela A Vivan; Jaqueline D C Horvath; Mariana L D de Castro; Rogério Friedman Journal: Obes Surg Date: 2018-09 Impact factor: 4.129